Screening and follow‐up of chronic liver diseases with understanding their etiology in clinics and hospitals-Reference-Cited by-同舟云学术

Screening and follow‐up of chronic liver diseases with understanding their etiology in clinics and hospitals

Published:2020-08-24 Issue:5 Volume:4 Page:827-837
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Ogawa Masahiro¹,Tsuchiya Atsunori¹^ORCID,Watanabe Takayuki¹,Setsu Toru¹,Kimura Naruhiro¹,Matsuda Masato²,Hoshiyama Yoshiki²,Saito Hiroaki³,Kanazawa Tsutomu³,Shiotani Motoi⁴,Sato Tatsuhiko⁴,Yagi Takuya⁴,Igarashi Koji⁵,Yoshimura Norihiko⁴,Takamura Masaaki¹,Aoyama Hidefumi⁴,Terai Shuji¹

Affiliation:

1. Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences Niigata University Niigata Japan

2. Medical Laboratory Division Niigata University Medical and Dental Hospital Niigata Japan

3. Division of Radiology, Department of Clinical Technology Niigata University Medical and Dental Hospital Niigata Japan

4. Department of Radiology and Radiation Oncology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan

5. Bioscience Division TOSOH Corporation Ayase‐shi Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12406

Reference34 articles.

1. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

2. Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

3. Chronic Hepatitis B Infection

4. A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update

5. Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibulin‐4 as a potential extracellular vesicle marker of fibrosis in patients with cirrhosis;FEBS Open Bio;2024-06-09

2. Long-term prediction of hepatocellular carcinoma using serum autotaxin levels after antiviral therapy for hepatitis C;Annals of Hepatology;2022-03

3. Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment;Inflammation and Regeneration;2021-09-16

4. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA;International Journal of Molecular Sciences;2021-07-29